Factor Vila and other Haemostatic Variables following Bone Marrow Transplantation
暂无分享,去创建一个
R. Chopra | A. Goldstone | P. Collins | E. Tuddenham | A. Newland | A. Goldstone | A. Newland | A. O’Driscoll | A. Roderick | D. O'Brien | P. Collins
[1] T. Drake,et al. Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis. , 1993, The American journal of pathology.
[2] P. Comp,et al. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. , 1993, Blood.
[3] Gianni,et al. Naturally occurring anticoagulants and bone marrow transplantation: plasma protein C predicts the development of venocclusive disease of the liver. , 1993, Blood.
[4] J. Armitage,et al. High frequency of antithrombin 3 and protein C deficiency following autologous bone marrow transplantation for lymphoma. , 1991, Bone marrow transplantation.
[5] E. Gluckman,et al. Liver veno-occlusive disease after bone marrow transplantation changes in coagulation parameters and endothelial markers. , 1991, Thrombosis research.
[6] R. Marcus,et al. Changes in the natural anticoagulants following bone marrow transplantation. , 1990, Bone marrow transplantation.
[7] W. Lehmacher,et al. Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation. , 1990, Blood.
[8] D. O'Brien. The molecular biology and biochemistry of tissue factor. , 1989, Bailliere's clinical haematology.
[9] C. Esmon,et al. Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture. , 1989, Blood.
[10] H. Prydz,et al. Cytokine-induced procoagulant activity in monocytes and endothelial cells. Further enhancement by cyclosporine. , 1988, Transplantation.
[11] F. Appelbaum,et al. Venocclusive disease of the liver after chemoradiotherapy and autologous bone marrow transplantation. , 1987, Transplantation.
[12] S. Rapaport,et al. Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation. , 1987, Blood.
[13] D. Stern,et al. Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[14] T. Gelehrter,et al. Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells. , 1986, The Journal of clinical investigation.
[15] Pankaj Sharma,et al. THE CLINICAL COURSE OF 53 PATIENTS WITH VENOCCLUSIVE DISEASE OF THE LIVER AFTER MARROW TRANSPLANTATION , 1985, Transplantation.
[16] Pankaj Sharma,et al. Venocclusive Disease of the Liver after Bone Marrow Transplantation: Diagnosis, Incidence, and Predisposing Factors , 1984, Hepatology.
[17] N. Semeraro,et al. Cultured human endothelial cells generate tissue factor in response to endotoxin. , 1983, The Journal of clinical investigation.
[18] K. Kopecky,et al. An analysis of hepatic venocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation. , 1980, Gastroenterology.